|
DE69939874D1
(en)
|
1998-09-02 |
2008-12-18 |
Diadexus Inc |
METHOD OF DIAGNOSIS, EVALUATION AND IMAGE DISPLAY OF VARIOUS CANCER DISORDERS
|
|
US20060035237A1
(en)
|
2002-08-26 |
2006-02-16 |
Markowitz Sanford D |
Methods and compositions for categorizing patients
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
US20050276812A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Antibody-drug conjugates and methods
|
|
EP1552845A4
(en)
*
|
2002-06-26 |
2006-06-07 |
Takeda Pharmaceutical |
Preventives/remedies for cancer
|
|
DE10230631A1
(en)
*
|
2002-07-02 |
2004-01-22 |
Metagen Pharmaceuticals Gmbh |
Uses of Ngal-binding substances for the diagnosis and treatment of cancer
|
|
WO2004005463A2
(en)
*
|
2002-07-03 |
2004-01-15 |
Aventis Pasteur Inc. |
Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer
|
|
US9200036B2
(en)
|
2002-07-12 |
2015-12-01 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
US20090110702A1
(en)
|
2002-07-12 |
2009-04-30 |
The Johns Hopkins University |
Mesothelin Vaccines and Model Systems and Control of Tumors
|
|
EP1575500A4
(en)
|
2002-07-12 |
2007-01-03 |
Univ Johns Hopkins |
Mesothelin vaccines and model systems
|
|
AU2002951346A0
(en)
*
|
2002-09-05 |
2002-09-26 |
Garvan Institute Of Medical Research |
Diagnosis of ovarian cancer
|
|
ES2359055T3
(en)
*
|
2002-09-11 |
2011-05-18 |
Genentech, Inc. |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TUMOR TREATMENT.
|
|
ES2388280T3
(en)
|
2002-12-20 |
2012-10-11 |
Abbott Biotherapeutics Corp. |
Antibodies that react to GPR64 and use them
|
|
US7294704B2
(en)
|
2003-08-15 |
2007-11-13 |
Diadexus, Inc. |
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
|
|
BR122018071968B8
(en)
|
2003-11-06 |
2021-07-27 |
Seattle Genetics Inc |
antibody-drug conjugate, pharmaceutical composition, article of manufacture and use of an antibody-drug conjugate
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
WO2005118840A2
(en)
*
|
2004-06-03 |
2005-12-15 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with kallikrein 10 (klk10)
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
NZ580115A
(en)
|
2004-09-23 |
2010-10-29 |
Genentech Inc |
Cysteine engineered antibody light chains and conjugates
|
|
JP4993645B2
(en)
|
2004-12-01 |
2012-08-08 |
ジェネンテック， インコーポレイテッド |
Antibody drug conjugates and methods
|
|
EP1963371A2
(en)
|
2005-12-08 |
2008-09-03 |
Medarex Inc. |
Human monoclonal antibodies to o8e
|
|
AU2007217861A1
(en)
|
2006-02-17 |
2007-08-30 |
Children's Medical Center Corporation |
Free NGAL as a biomarker for cancer
|
|
TWI397535B
(en)
|
2006-03-21 |
2013-06-01 |
Genentech Inc |
Combinatorial therapy involving alpha5beta1 antagonists
|
|
ES2444695T3
(en)
*
|
2006-06-23 |
2014-02-26 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptides involved in cancer
|
|
TWI438207B
(en)
*
|
2007-02-21 |
2014-05-21 |
Oncotherapy Science Inc |
Peptide vaccines for cancers expressing tumor-associated antigens
|
|
WO2008104803A2
(en)
*
|
2007-02-26 |
2008-09-04 |
Oxford Genome Sciences (Uk) Limited |
Proteins
|
|
AU2008296927C1
(en)
*
|
2007-09-06 |
2015-08-13 |
Case Western Reserve University |
Methods for diagnosing and treating cancers
|
|
TWI547503B
(en)
|
2007-09-26 |
2016-09-01 |
建南德克公司 |
Anti-α5β1 antibodies, nucleic acids encoding and compositions comprising the same, and methods of production and use thereof
|
|
CA2700860C
(en)
|
2007-10-01 |
2016-07-19 |
Jonathan A. Terrett |
Human antibodies that bind mesothelin, and uses thereof
|
|
EP2060583A1
(en)
|
2007-10-23 |
2009-05-20 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated markers for diagnosis and therapy
|
|
JP6067222B2
(en)
|
2008-07-15 |
2017-01-25 |
ジェネンテック， インコーポレイテッド |
Anthracycline derivative conjugates, methods for their preparation and their use as antitumor compounds
|
|
TW201008574A
(en)
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
|
CN102264897B
(en)
|
2008-10-22 |
2014-06-11 |
肿瘤疗法科学股份有限公司 |
Rab6kifl/kif20a epitope peptide and vaccines containing the same
|
|
CN104829714A
(en)
|
2008-11-03 |
2015-08-12 |
阿莱斯亚生物疗法股份有限公司 |
Antibodies that specifically block the biological activity of a tumor antigen
|
|
SG10201609416XA
(en)
|
2009-03-25 |
2016-12-29 |
Genentech Inc |
NOVEL ANTI-α5ß1 ANTIBODIES AND USES THEREOF
|
|
AU2010292172A1
(en)
|
2009-09-09 |
2012-05-03 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
|
CN103724432B
(en)
|
2009-11-30 |
2016-06-08 |
霍夫曼-拉罗奇有限公司 |
The antibody that the tumour of SLC34A2 (TAT211=SEQID2) is expressed in treatment and diagnosis
|
|
PE20130342A1
(en)
|
2010-04-15 |
2013-04-20 |
Spirogen Sarl |
PIRROLOBENZODIACEPINES AND CONJUGATES OF THE SAME
|
|
CN114246952A
(en)
|
2010-06-08 |
2022-03-29 |
基因泰克公司 |
Cysteine engineered antibodies and conjugates
|
|
LT2621526T
(en)
|
2010-09-29 |
2018-09-25 |
Agensys, Inc. |
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
|
|
JP5889912B2
(en)
|
2010-11-17 |
2016-03-22 |
ジェネンテック， インコーポレイテッド |
Alaninyl maytansinol antibody conjugate
|
|
CN107098972A
(en)
|
2010-12-20 |
2017-08-29 |
霍夫曼-拉罗奇有限公司 |
Anti-mesothelin antibodies and immunoconjugates
|
|
DK3173427T3
(en)
|
2011-03-31 |
2019-08-05 |
Adc Therapeutics Sa |
ANTIBODIES AGAINST NON-ASSOCIATED ANTIGEN 1 AND ANTIGEN-BINDING FRAGMENTS THEREOF
|
|
JP5987053B2
(en)
|
2011-05-12 |
2016-09-06 |
ジェネンテック， インコーポレイテッド |
Multiple reaction monitoring LC-MS / MS method for detecting therapeutic antibodies in animal samples using framework signature peptides
|
|
PT2750713E
(en)
|
2011-10-14 |
2016-01-20 |
Genentech Inc |
Pyrrolobenzodiazepines and conjugates thereof
|
|
ES2731665T3
(en)
|
2012-01-09 |
2019-11-18 |
Adc Therapeutics Sa |
Agents to treat triple negative breast cancer
|
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
|
WO2014057120A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
ES2680153T3
(en)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Anti-PSMA-pyrrolobenzodiazepine antibody conjugates
|
|
KR101995621B1
(en)
|
2012-10-12 |
2019-07-03 |
에이디씨 테라퓨틱스 에스에이 |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
|
RS53818B1
(en)
|
2012-10-12 |
2015-06-30 |
Spirogen Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CA2887895C
(en)
|
2012-10-12 |
2019-10-29 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-cd19 antibody conjugates
|
|
PT2906296T
(en)
|
2012-10-12 |
2018-06-01 |
Medimmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
JP6270859B2
(en)
|
2012-10-12 |
2018-01-31 |
エイディーシー・セラピューティクス・エス・アー・エール・エルＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａｒｌ |
Pyrrolobenzodiazepine-antibody conjugate
|
|
CN110452242A
(en)
|
2012-12-21 |
2019-11-15 |
麦迪穆有限责任公司 |
Pyrrolobenzodiazepines Zhuo and its conjugate
|
|
CN105246894A
(en)
|
2012-12-21 |
2016-01-13 |
斯皮罗根有限公司 |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
|
US20150362497A1
(en)
*
|
2013-01-31 |
2015-12-17 |
Arizona Board of Regents on behalf of Arizona Stat State University |
Autoantibody Signature for the Early Detection of Ovarian Cancer
|
|
KR102057755B1
(en)
|
2013-03-13 |
2019-12-19 |
메디뮨 리미티드 |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CA2905181C
(en)
|
2013-03-13 |
2020-06-02 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy
|
|
JP6340019B2
(en)
|
2013-03-13 |
2018-06-06 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
Pyrrolobenzodiazepine and its conjugates
|
|
KR20160042080A
(en)
|
2013-08-12 |
2016-04-18 |
제넨테크, 인크. |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
EP3054983B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US9956299B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepine—antibody conjugates
|
|
US9950078B2
(en)
|
2013-10-11 |
2018-04-24 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
LT3055331T
(en)
|
2013-10-11 |
2021-03-25 |
Oxford Bio Therapeutics Limited |
Conjugated antibodies against ly75 for the treatment of cancer
|
|
JP6671292B2
(en)
|
2013-12-16 |
2020-03-25 |
ジェネンテック， インコーポレイテッド |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
|
MX2016007826A
(en)
|
2013-12-16 |
2017-03-31 |
Genentech Inc |
Peptidomimetic compounds and antibody-drug conjugates thereof.
|
|
WO2015095212A1
(en)
|
2013-12-16 |
2015-06-25 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
WO2016037644A1
(en)
|
2014-09-10 |
2016-03-17 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP3191134B1
(en)
|
2014-09-12 |
2019-11-20 |
Genentech, Inc. |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
|
KR20170052600A
(en)
|
2014-09-12 |
2017-05-12 |
제넨테크, 인크. |
Cysteine engineered antibodies and conjugates
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CA2959689A1
(en)
|
2014-09-17 |
2016-03-24 |
Genentech, Inc. |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
|
|
EP3223854A1
(en)
|
2014-11-25 |
2017-10-04 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CN107206101B
(en)
|
2014-12-03 |
2021-06-25 |
基因泰克公司 |
Quaternary ammonium compounds and antibody-drug conjugates thereof
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
MA43345A
(en)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
|
|
MY198087A
(en)
|
2015-10-05 |
2023-07-31 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
|
|
MA43354A
(en)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE
|
|
MA45326A
(en)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
JP6943872B2
(en)
|
2016-03-25 |
2021-10-06 |
ジェネンテック， インコーポレイテッド |
Multiple whole antibody and antibody complex drug quantification assay
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
PL3458101T3
(en)
|
2016-05-20 |
2021-05-31 |
F. Hoffmann-La Roche Ag |
Protac antibody conjugates and methods of use
|
|
US20170370906A1
(en)
|
2016-05-27 |
2017-12-28 |
Genentech, Inc. |
Bioanalytical analysis of site-specific antibody drug conjugates
|
|
US10639378B2
(en)
|
2016-06-06 |
2020-05-05 |
Genentech, Inc. |
Silvestrol antibody-drug conjugates and methods of use
|
|
CN109689111B
(en)
|
2016-08-11 |
2024-04-05 |
基因泰克公司 |
Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
|
|
CN110139674B
(en)
|
2016-10-05 |
2023-05-16 |
豪夫迈·罗氏有限公司 |
Method for preparing antibody drug conjugates
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
US11160872B2
(en)
|
2017-02-08 |
2021-11-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CN110582505B
(en)
|
2017-04-18 |
2021-04-02 |
免疫医疗有限公司 |
Pyrrolobenzodiazepine conjugates
|
|
CN110536703A
(en)
|
2017-04-20 |
2019-12-03 |
Adc治疗有限公司 |
Use Anti-AXL antibodies-drug conjugate combination treatment
|
|
US11318211B2
(en)
|
2017-06-14 |
2022-05-03 |
Adc Therapeutics Sa |
Dosage regimes for the administration of an anti-CD19 ADC
|
|
SI3668874T1
(en)
|
2017-08-18 |
2022-04-29 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
RU2020113749A
(en)
|
2017-09-20 |
2021-10-20 |
пиЭйч ФАРМА Ко., ЛТД. |
ANALOGUES OF THAILANSTATIN
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
|
AU2019365238A1
(en)
|
2018-10-24 |
2021-05-13 |
F. Hoffmann-La Roche Ag |
Conjugated chemical inducers of degradation and methods of use
|
|
EP3894427A1
(en)
|
2018-12-10 |
2021-10-20 |
Genentech, Inc. |
Photocrosslinking peptides for site specific conjugation to fc-containing proteins
|
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
|
TW202216215A
(en)
|
2020-07-21 |
2022-05-01 |
美商建南德克公司 |
Antibody-conjugated chemical inducers of degradation of brm and methods thereof
|
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
|
AR128331A1
(en)
|
2022-01-26 |
2024-04-17 |
Genentech Inc |
CHEMICAL DEGRADATION INDUCTORS CONJUGATED WITH ANTIBODIES AND METHODS OF THESE
|
|
AR128330A1
(en)
|
2022-01-26 |
2024-04-17 |
Genentech Inc |
CHEMICAL DEGRADATION INDUCERS CONJUGATED WITH ANTIBODY AND METHODS OF THESE
|